The aim of this study is to investigate peripheral effects of Somatostatin on glucose
metabolism and growth hormone (GH) signalling in healthy men. Eight subjects will be
enrolled. The hypothesis is that Somatostatin infusion reverses insulin resistance caused by
GH.
Phase:
N/A
Details
Lead Sponsor:
University of Aarhus
Collaborator:
The Ministry of Science, Technology and Innovation, Denmark